Risk of Myocardial Infarction and Death After Noncardiac Surgery Performed Within the First Year After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome or Stable Angina Pectoris.
Acute Coronary Syndrome
/ surgery
Aged
Angina, Stable
/ surgery
Cause of Death
Cohort Studies
Coronary Artery Disease
/ surgery
Drug-Eluting Stents
Female
Humans
Logistic Models
Male
Middle Aged
Mortality
Myocardial Infarction
/ epidemiology
Postoperative Complications
/ epidemiology
Surgical Procedures, Operative
Journal
The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
received:
16
05
2021
revised:
13
08
2021
accepted:
16
08
2021
pubmed:
30
9
2021
medline:
20
11
2021
entrez:
29
9
2021
Statut:
ppublish
Résumé
This study aimed to examine the 30-day risk of myocardial infarction (MI) and death in patients who underwent noncardiac surgery within 1 year after coronary drug-eluting stent implantation for acute coronary syndrome (ACS) or stable angina pectoris (SAP) and to compare it with the risk in surgical patients without known coronary artery disease. Patients with drug-eluting stent implantation for ACS (n = 2,291) or SAP (n = 1,804) who underwent noncardiac surgery were compared with a cohort from the general population without known coronary artery disease matched on the surgical procedure, hospital contact type, gender, and age. In patients with ACS, the 30-day MI risk was markedly increased when surgery was performed within 1 month after stenting (10% vs 0.8%; adjusted odds ratio [OR
Identifiants
pubmed: 34583812
pii: S0002-9149(21)00824-9
doi: 10.1016/j.amjcard.2021.08.040
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14-20Informations de copyright
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosures The authors have no conflicts of interest to disclose.